Streetbeat News

Regulatory

TLT

Mortgage rates have risen above 7% due to hot inflation and reduced expectations for Federal Reserve rate cuts. The average rate for 30-year fixed-rate mortgages reached 7.06%, causing a 10.6% drop in mortgage applications. Inflation data for January showed a rise, leading to adjustments in rate cut expectations and an increase in Treasury yields. The iShares 20+ Year Treasury Bond ETF (TLT) experienced a 4% decline this month, its worst performance since October.

Portfolio Pulse from Piero Cingari

February 21, 2024 | 2:07 pm

MOTS

Motus GI Holdings has been granted a U.S. patent for a feature of its Pure-Vu System designed to prevent clogging during the cleansing of the gastrointestinal (GI) tract. This development could enhance the system's efficiency and reliability, potentially leading to increased adoption in medical facilities.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:53 pm

MOTS

Motus GI's stock price increased following the announcement that the company has been granted U.S. Patent #11904085 for 'Systems And Methods For Cleaning A Colon.' This patent strengthens the company's intellectual property portfolio, potentially enhancing its competitive position in the medical device market.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:39 pm

COYA

Coya Therapeutics is expanding its COYA 302 product into Alzheimer's Disease, leveraging its proprietary low-dose interleukin-2 formulation and CTLA4-Ig combination. This expansion follows partnerships and planned IND filings for ALS, FTD, and PD, with a double-blind trial for LD IL-2 in AD ongoing. The company highlights its 'Pipeline in a Product' approach, aiming to address neurodegenerative diseases' complex immune pathways. With a two-year cash runway and anticipated milestones in 2024, Coya aims to deliver therapies for neurodegenerative diseases affecting millions in the U.S.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:32 pm

AMRC

Ameresco, Inc. (NYSE:AMRC) has been awarded by Hawaiian Electric Company to develop the 'Ūkiu Energy 40MW renewable energy site in Maui, enhancing grid reliability and advancing Hawaii's clean energy goals. The facility, featuring a biofuel-powered generator with six dual-fuel engines, will support decarbonization, reduce Maui's fossil fuel dependence, and provide 24/7 renewable energy. This project, pending Public Utilities Commission approval, is part of Hawaiian Electric's clean energy procurement phase and will be built, owned, and operated by Ameresco. It marks Ameresco's fourth award with Hawaiian Electric, following the Kūpono Solar, Pu`uloa Energy, and Pu`uloa Solar projects.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:30 pm

ABOS

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) announced its plans to present data from the Phase 1 INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's treatment at the AD/PD 2024 meeting. The study showed sabirnetug to be well-tolerated with a favorable safety profile and significant amyloid plaque reduction. Acumen is set to initiate a Phase 2 trial in the first half of 2024, highlighting sabirnetug's potential as a next-generation treatment for early Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:24 pm

MRVI

TriLink BioTechnologies, a subsidiary of Maravai LifeSciences (NASDAQ:MRVI), has secured patents in China and Canada for its CleanCap® Capping Technology, crucial for mRNA-based therapeutics and vaccines production. These patents add to the global IP portfolio, with CleanCap® already patented in major markets including the US and EU. The technology enhances mRNA production efficiency and has been used in COVID-19 vaccines. TriLink's CleanCap® M6 analog, launched last May, promises to further reduce manufacturing times and costs while increasing protein expression and mRNA yields.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:14 pm

HCAT

Health Catalyst, Inc. (NASDAQ:HCAT) announced that its MeasureAble application has achieved ONC Health IT 2015 Edition certification through Drummond Group LLC. This certification allows eligible providers and hospitals to use MeasureAble for various quality reporting programs, leveraging certified EHR technology. MeasureAble offers over 240 regulatory measures and combines data, calculations, and visualizations in one application, aiming to support healthcare transformation and performance improvement.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:12 pm

AON

Aon plc and NFP announced the expiration of the Hart-Scott-Rodino Antitrust Act waiting period for their proposed acquisition agreement. The transaction, expected to close in mid-2024, is still subject to other regulatory approvals and customary closing conditions. Both companies will operate independently until the closing.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:10 pm

JOBY

Joby has successfully completed the third of five stages in the FAA type certification process, becoming the first eVTOL company to achieve this milestone towards commercialization.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:10 pm